{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,21]],"date-time":"2026-05-21T11:09:53Z","timestamp":1779361793261,"version":"3.51.4"},"publisher-location":"Cham","reference-count":57,"publisher":"Springer Nature Switzerland","isbn-type":[{"value":"9783032214140","type":"print"},{"value":"9783032214157","type":"electronic"}],"license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026]]},"DOI":"10.1007\/978-3-032-21415-7_7","type":"book-chapter","created":{"date-parts":[[2026,5,21]],"date-time":"2026-05-21T10:10:57Z","timestamp":1779358257000},"page":"803-821","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Clinical PET\/MR"],"prefix":"10.1007","author":[{"given":"Wolfgang","family":"Weber","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,5,22]]},"reference":[{"key":"7_CR1","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1007\/s11307-013-0623-1","volume":"15","author":"DL Bailey","year":"2013","unstructured":"Bailey DL, Barthel H, Beyer T, Boellaard R, Guckel B, Hellwig D et al (2013) Summary report of the first international workshop on PET\/MR imaging, March 19\u201323, 2012, Tubingen, Germany. Mol Imaging Biol 15:361\u2013371","journal-title":"Mol Imaging Biol"},{"key":"7_CR2","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1007\/s11307-014-0818-0","volume":"17","author":"DL Bailey","year":"2015","unstructured":"Bailey DL, Antoch G, Bartenstein P, Barthel H, Beer AJ, Bisdas S et al (2015) Combined PET\/MR: the real work has just started. Summary report of the third international workshop on PET\/MR imaging; February 17\u201321, 2014, Tubingen, Germany. Mol Imaging Biol 17:297\u2013312","journal-title":"Mol Imaging Biol"},{"key":"7_CR3","doi-asserted-by":"publisher","first-page":"2097","DOI":"10.1016\/j.ejrad.2015.08.010","volume":"84","author":"J Grueneisen","year":"2015","unstructured":"Grueneisen J, Schaarschmidt BM, Heubner M, Suntharalingam S, Milk I, Kinner S et al (2015) Implementation of FAST-PET\/MRI for whole-body staging of female patients with recurrent pelvic malignancies: a comparison to PET\/CT. Eur J Radiol 84:2097\u20132102","journal-title":"Eur J Radiol"},{"key":"7_CR4","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0157880","volume":"11","author":"J Grueneisen","year":"2016","unstructured":"Grueneisen J, Sawicki LM, Schaarschmidt BM, Suntharalingam S, von der Ropp S, Wetter A et al (2016) Evaluation of a fast protocol for staging lymphoma patients with integrated PET\/MRI. PLoS One 11:e0157880","journal-title":"PLoS One"},{"key":"7_CR5","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1016\/j.ejrad.2016.12.019","volume":"89","author":"J Grueneisen","year":"2017","unstructured":"Grueneisen J, Sawicki LM, Wetter A, Kirchner J, Kinner S, Aktas B et al (2017) Evaluation of PET and MR datasets in integrated 18F-FDG PET\/MRI: a comparison of different MR sequences for whole-body restaging of breast cancer patients. Eur J Radiol 89:14\u201319","journal-title":"Eur J Radiol"},{"key":"7_CR6","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0172553","volume":"12","author":"J Kirchner","year":"2017","unstructured":"Kirchner J, Sawicki LM, Suntharalingam S, Grueneisen J, Ruhlmann V, Aktas B et al (2017) Whole-body staging of female patients with recurrent pelvic malignancies: ultra-fast 18F-FDG PET\/MRI compared to 18F-FDG PET\/CT and CT. PLoS One 12:e0172553","journal-title":"PLoS One"},{"key":"7_CR7","doi-asserted-by":"publisher","first-page":"420","DOI":"10.2967\/jnumed.115.158808","volume":"57","author":"C Spick","year":"2016","unstructured":"Spick C, Herrmann K, Czernin J (2016) 18F-FDG PET\/CT and PET\/MRI perform equally well in cancer: evidence from studies on more than 2,300 patients. J Nucl Med 57:420\u2013430","journal-title":"J Nucl Med"},{"key":"7_CR8","doi-asserted-by":"publisher","first-page":"551","DOI":"10.2967\/jnumed.113.125443","volume":"55","author":"FP Kuhn","year":"2014","unstructured":"Kuhn FP, Hullner M, Mader CE, Kastrinidis N, Huber GF, von Schulthess GK et al (2014) Contrast-enhanced PET\/MR imaging versus contrast-enhanced PET\/CT in head and neck cancer: how much MR information is needed? J Nucl Med 55:551\u2013558","journal-title":"J Nucl Med"},{"key":"7_CR9","doi-asserted-by":"publisher","first-page":"1163","DOI":"10.1016\/j.ejrad.2014.03.023","volume":"83","author":"I Platzek","year":"2014","unstructured":"Platzek I, Beuthien-Baumann B, Schneider M, Gudziol V, Kitzler HH, Maus J et al (2014) FDG PET\/MR for lymph node staging in head and neck cancer. Eur J Radiol 83:1163\u20131168","journal-title":"Eur J Radiol"},{"key":"7_CR10","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1007\/s00259-015-3145-z","volume":"43","author":"BM Schaarschmidt","year":"2016","unstructured":"Schaarschmidt BM, Heusch P, Buchbender C, Ruhlmann M, Bergmann C, Ruhlmann V et al (2016) Locoregional tumour evaluation of squamous cell carcinoma in the head and neck area: a comparison between MRI, PET\/CT and integrated PET\/MRI. Eur J Nucl Med Mol Imaging 43:92\u2013102","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"7_CR11","doi-asserted-by":"publisher","first-page":"1297","DOI":"10.1007\/s00259-018-3986-3","volume":"45","author":"SC Chan","year":"2018","unstructured":"Chan SC, Yeh CH, Yen TC, Ng SH, Chang JT, Lin CY et al (2018) Clinical utility of simultaneous whole-body (18)F-FDG PET\/MRI as a single-step imaging modality in the staging of primary nasopharyngeal carcinoma. Eur J Nucl Med Mol Imaging 45:1297\u20131308","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"7_CR12","doi-asserted-by":"publisher","DOI":"10.1002\/lary.27911","volume":"130","author":"K Hayashi","year":"2019","unstructured":"Hayashi K, Kikuchi M, Imai Y, Yamashita D, Hino M, Ito K et al (2019) Clinical value of fused PET\/MRI for surgical planning in patients with Oral\/oropharyngeal carcinoma. Laryngoscope 130:367","journal-title":"Laryngoscope"},{"key":"7_CR13","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1007\/s00259-013-2633-2","volume":"41","author":"K Kubiessa","year":"2014","unstructured":"Kubiessa K, Purz S, Gawlitza M, Kuhn A, Fuchs J, Steinhoff KG et al (2014) Initial clinical results of simultaneous 18F-FDG PET\/MRI in comparison to 18F-FDG PET\/CT in patients with head and neck cancer. Eur J Nucl Med Mol Imaging 41:639\u2013648","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"7_CR14","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1016\/j.cpet.2016.05.002","volume":"11","author":"I Platzek","year":"2016","unstructured":"Platzek I (2016) (18)F-Fluorodeoxyglucose PET\/MR imaging in head and neck cancer. PET Clin 11:375\u2013386","journal-title":"PET Clin"},{"key":"7_CR15","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1016\/j.clinimag.2017.01.003","volume":"42","author":"T Sekine","year":"2017","unstructured":"Sekine T, de Galiza Barbosa F, Kuhn FP, Burger IA, Stolzmann P, Huber GF et al (2017) PET+MR versus PET\/CT in the initial staging of head and neck cancer, using a trimodality PET\/CT+MR system. Clin Imaging 42:232\u2013239","journal-title":"Clin Imaging"},{"key":"7_CR16","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1016\/j.crad.2017.09.001","volume":"73","author":"TA Szyszko","year":"2018","unstructured":"Szyszko TA, Cook GJR (2018) PET\/CT and PET\/MRI in head and neck malignancy. Clin Radiol 73:60\u201369","journal-title":"Clin Radiol"},{"key":"7_CR17","doi-asserted-by":"publisher","first-page":"1432","DOI":"10.1007\/s00261-015-0409-9","volume":"40","author":"TA Hope","year":"2015","unstructured":"Hope TA, Pampaloni MH, Nakakura E, VanBrocklin H, Slater J, Jivan S et al (2015) Simultaneous (68)Ga-DOTA-TOC PET\/MRI with gadoxetate disodium in patients with neuroendocrine tumor. Abdom Imaging 40:1432\u20131440","journal-title":"Abdom Imaging"},{"key":"7_CR18","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0180349","volume":"12","author":"J Kirchner","year":"2017","unstructured":"Kirchner J, Sawicki LM, Deuschl C, Gruneisen J, Beiderwellen K, Lauenstein TC et al (2017) 18 F-FDG PET\/MR imaging in patients with suspected liver lesions: value of liver-specific contrast agent Gadobenate dimeglumine. PLoS One 12:e0180349","journal-title":"PLoS One"},{"key":"7_CR19","doi-asserted-by":"publisher","first-page":"1978","DOI":"10.1007\/s00330-013-2785-2","volume":"23","author":"ME Mayerhoefer","year":"2013","unstructured":"Mayerhoefer ME, Ba-Ssalamah A, Weber M, Mitterhauser M, Eidherr H, Wadsak W et al (2013) Gadoxetate-enhanced versus diffusion-weighted MRI for fused Ga-68-DOTANOC PET\/MRI in patients with neuroendocrine tumours of the upper abdomen. Eur Radiol 23:1978\u20131985","journal-title":"Eur Radiol"},{"key":"7_CR20","doi-asserted-by":"publisher","first-page":"782","DOI":"10.1148\/radiol.2016151975","volume":"280","author":"DH Lee","year":"2016","unstructured":"Lee DH, Lee JM, Hur BY, Joo I, Yi NJ, Suh KS et al (2016) Colorectal cancer liver metastases: diagnostic performance and prognostic value of PET\/MR imaging. Radiology 280:782\u2013792","journal-title":"Radiology"},{"key":"7_CR21","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1007\/s00259-013-2654-x","volume":"41","author":"CS Reiner","year":"2014","unstructured":"Reiner CS, Stolzmann P, Husmann L, Burger IA, Hullner MW, Schaefer NG et al (2014) Protocol requirements and diagnostic value of PET\/MR imaging for liver metastasis detection. Eur J Nucl Med Mol Imaging 41:649\u2013658","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"7_CR22","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0137285","volume":"10","author":"K Beiderwellen","year":"2015","unstructured":"Beiderwellen K, Geraldo L, Ruhlmann V, Heusch P, Gomez B, Nensa F et al (2015) Accuracy of [18F]FDG PET\/MRI for the detection of liver metastases. PLoS One 10:e0137285","journal-title":"PLoS One"},{"key":"7_CR23","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1007\/s00259-014-2902-8","volume":"42","author":"K Beiderwellen","year":"2015","unstructured":"Beiderwellen K, Grueneisen J, Ruhlmann V, Buderath P, Aktas B, Heusch P et al (2015) [(18)F]FDG PET\/MRI vs. PET\/CT for whole-body staging in patients with recurrent malignancies of the female pelvis: initial results. Eur J Nucl Med Mol Imaging 42:56\u201365","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"7_CR24","doi-asserted-by":"publisher","first-page":"622","DOI":"10.1007\/s00259-017-3881-3","volume":"45","author":"LM Sawicki","year":"2018","unstructured":"Sawicki LM, Kirchner J, Grueneisen J, Ruhlmann V, Aktas B, Schaarschmidt BM et al (2018) Comparison of (18)F-FDG PET\/MRI and MRI alone for whole-body staging and potential impact on therapeutic management of women with suspected recurrent pelvic cancer: a follow-up study. Eur J Nucl Med Mol Imaging 45:622\u2013629","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"7_CR25","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1186\/s40644-020-00372-5","volume":"21","author":"A Steiner","year":"2021","unstructured":"Steiner A, Narva S, Rinta-Kiikka I, Hietanen S, Hynninen J, Virtanen J (2021) Diagnostic efficiency of whole-body (18)F-FDG PET\/MRI, MRI alone, and SUV and ADC values in staging of primary uterine cervical cancer. Cancer Imaging 21:16","journal-title":"Cancer Imaging"},{"key":"7_CR26","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1186\/s40644-020-00357-4","volume":"20","author":"H Tsuyoshi","year":"2020","unstructured":"Tsuyoshi H, Tsujikawa T, Yamada S, Okazawa H, Yoshida Y (2020) Diagnostic value of (18)F-FDG PET\/MRI for staging in patients with endometrial cancer. Cancer Imaging 20:75","journal-title":"Cancer Imaging"},{"key":"7_CR27","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1186\/s13550-020-00712-3","volume":"10","author":"H Tsuyoshi","year":"2020","unstructured":"Tsuyoshi H, Tsujikawa T, Yamada S, Okazawa H, Yoshida Y (2020) Diagnostic value of [(18)F]FDG PET\/MRI for staging in patients with ovarian cancer. EJNMMI Res 10:117","journal-title":"EJNMMI Res"},{"key":"7_CR28","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1148\/radiol.2016151155","volume":"281","author":"AN Melsaether","year":"2016","unstructured":"Melsaether AN, Raad RA, Pujara AC, Ponzo FD, Pysarenko KM, Jhaveri K et al (2016) Comparison of whole-body (18)F FDG PET\/MR imaging and whole-body (18)F FDG PET\/CT in terms of lesion detection and radiation dose in patients with breast cancer. Radiology 281:193\u2013202","journal-title":"Radiology"},{"key":"7_CR29","doi-asserted-by":"publisher","first-page":"1787","DOI":"10.1007\/s00330-018-5720-8","volume":"29","author":"D Botsikas","year":"2019","unstructured":"Botsikas D, Bagetakos I, Picarra M, Da Cunha Afonso Barisits AC, Boudabbous S, Montet X et al (2019) What is the diagnostic performance of 18-FDG-PET\/MR compared to PET\/CT for the N- and M- staging of breast cancer? Eur Radiol 29:1787\u20131798","journal-title":"Eur Radiol"},{"key":"7_CR30","doi-asserted-by":"publisher","first-page":"8714","DOI":"10.1007\/s00330-021-07956-0","volume":"31","author":"NM Bruckmann","year":"2021","unstructured":"Bruckmann NM, Kirchner J, Umutlu L, Fendler WP, Seifert R, Herrmann K et al (2021) Prospective comparison of the diagnostic accuracy of 18F-FDG PET\/MRI, MRI, CT, and bone scintigraphy for the detection of bone metastases in the initial staging of primary breast cancer patients. Eur Radiol 31:8714\u20138724","journal-title":"Eur Radiol"},{"key":"7_CR31","doi-asserted-by":"publisher","first-page":"992","DOI":"10.1007\/s00259-021-05502-0","volume":"49","author":"J Morawitz","year":"2022","unstructured":"Morawitz J, Bruckmann NM, Dietzel F, Ullrich T, Bittner AK, Hoffmann O et al (2022) Comparison of nodal staging between CT, MRI, and [(18)F]-FDG PET\/MRI in patients with newly diagnosed breast cancer. Eur J Nucl Med Mol Imaging 49:992\u20131001","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"7_CR32","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1097\/RLI.0000000000000197","volume":"50","author":"J Grueneisen","year":"2015","unstructured":"Grueneisen J, Nagarajah J, Buchbender C, Hoffmann O, Schaarschmidt BM, Poeppel T et al (2015) Positron emission tomography\/magnetic resonance imaging for local tumor staging in patients with primary breast cancer: a comparison with positron emission tomography\/computed tomography and magnetic resonance imaging. Investig Radiol 50:505\u2013513","journal-title":"Investig Radiol"},{"key":"7_CR33","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1016\/j.ejrad.2013.11.002","volume":"83","author":"L Pace","year":"2014","unstructured":"Pace L, Nicolai E, Luongo A, Aiello M, Catalano OA, Soricelli A et al (2014) Comparison of whole-body PET\/CT and PET\/MRI in breast cancer patients: lesion detection and quantitation of 18F-deoxyglucose uptake in lesions and in normal organ tissues. Eur J Radiol 83:289\u2013296","journal-title":"Eur J Radiol"},{"key":"7_CR34","doi-asserted-by":"publisher","first-page":"2297","DOI":"10.1007\/s00330-015-4054-z","volume":"26","author":"D Botsikas","year":"2016","unstructured":"Botsikas D, Kalovidouri A, Becker M, Copercini M, Djema DA, Bodmer A et al (2016) Clinical utility of 18F-FDG-PET\/MR for preoperative breast cancer staging. Eur Radiol 26:2297\u20132307","journal-title":"Eur Radiol"},{"key":"7_CR35","doi-asserted-by":"publisher","first-page":"506","DOI":"10.1097\/RLU.0000000000001684","volume":"42","author":"J Wang","year":"2017","unstructured":"Wang J, Shih TT, Yen RF (2017) Multiparametric evaluation of treatment response to neoadjuvant chemotherapy in breast cancer using integrated PET\/MR. Clin Nucl Med 42:506\u2013513","journal-title":"Clin Nucl Med"},{"key":"7_CR36","doi-asserted-by":"publisher","first-page":"1767","DOI":"10.1056\/NEJMoa1801993","volume":"378","author":"V Kasivisvanathan","year":"2018","unstructured":"Kasivisvanathan V, Rannikko AS, Borghi M, Panebianco V, Mynderse LA, Vaarala MH et al (2018) MRI-targeted or standard biopsy for prostate-cancer diagnosis. N Engl J Med 378:1767\u20131777","journal-title":"N Engl J Med"},{"key":"7_CR37","doi-asserted-by":"publisher","first-page":"815","DOI":"10.1016\/S0140-6736(16)32401-1","volume":"389","author":"HU Ahmed","year":"2017","unstructured":"Ahmed HU, El-Shater Bosaily A, Brown LC, Gabe R, Kaplan R, Parmar MK et al (2017) Diagnostic accuracy of multi-parametric MRI and TRUS biopsy in prostate cancer (PROMIS): a paired validating confirmatory study. Lancet 389:815\u2013822","journal-title":"Lancet"},{"key":"7_CR38","doi-asserted-by":"publisher","first-page":"1415","DOI":"10.1001\/jamaoncol.2016.5840","volume":"3","author":"ML Lindenberg","year":"2017","unstructured":"Lindenberg ML, Turkbey B, Mena E, Choyke PL (2017) Imaging locally advanced, recurrent, and metastatic prostate cancer: a review. JAMA Oncol 3:1415\u20131422","journal-title":"JAMA Oncol"},{"key":"7_CR39","doi-asserted-by":"publisher","first-page":"793","DOI":"10.1148\/radiol.2016152542","volume":"280","author":"AB Rosenkrantz","year":"2016","unstructured":"Rosenkrantz AB, Ginocchio LA, Cornfeld D, Froemming AT, Gupta RT, Turkbey B et al (2016) Interobserver reproducibility of the PI-RADS version 2 lexicon: a multicenter study of six experienced prostate radiologists. Radiology 280:793\u2013804","journal-title":"Radiology"},{"key":"7_CR40","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1016\/j.ejrad.2019.02.028","volume":"113","author":"M Li","year":"2019","unstructured":"Li M, Huang Z, Yu H, Wang Y, Zhang Y, Song B (2019) Comparison of PET\/MRI with multiparametric MRI in diagnosis of primary prostate cancer: a meta-analysis. Eur J Radiol 113:225\u2013231","journal-title":"Eur J Radiol"},{"key":"7_CR41","doi-asserted-by":"publisher","first-page":"829","DOI":"10.1016\/j.eururo.2015.12.053","volume":"70","author":"M Eiber","year":"2016","unstructured":"Eiber M, Weirich G, Holzapfel K, Souvatzoglou M, Haller B, Rauscher I et al (2016) Simultaneous (68)Ga-PSMA HBED-CC PET\/MRI improves the localization of primary prostate cancer. Eur Urol 70:829\u2013836","journal-title":"Eur Urol"},{"key":"7_CR42","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1159\/000484695","volume":"100","author":"M Al-Bayati","year":"2018","unstructured":"Al-Bayati M, Grueneisen J, Lutje S, Sawicki LM, Suntharalingam S, Tschirdewahn S et al (2018) Integrated 68Gallium labelled prostate-specific membrane Antigen-11 positron emission tomography\/magnetic resonance imaging enhances discriminatory power of multi-parametric prostate magnetic resonance imaging. Urol Int 100:164\u2013171","journal-title":"Urol Int"},{"key":"7_CR43","doi-asserted-by":"publisher","first-page":"1338","DOI":"10.2214\/AJR.17.18881","volume":"210","author":"S Taneja","year":"2018","unstructured":"Taneja S, Jena A, Taneja R, Singh A, Ahuja A (2018) Effect of combined (68)Ga-PSMAHBED-CC uptake pattern and multiparametric MRI derived with simultaneous PET\/MRI in the diagnosis of primary prostate cancer: initial experience. AJR Am J Roentgenol 210:1338\u20131345","journal-title":"AJR Am J Roentgenol"},{"key":"7_CR44","doi-asserted-by":"publisher","first-page":"730","DOI":"10.1148\/radiol.2018180788","volume":"289","author":"RM Hicks","year":"2018","unstructured":"Hicks RM, Simko JP, Westphalen AC, Nguyen HG, Greene KL, Zhang L et al (2018) Diagnostic accuracy of (68)Ga-PSMA-11 PET\/MRI compared with multiparametric MRI in the detection of prostate cancer. Radiology 289:730\u2013737","journal-title":"Radiology"},{"key":"7_CR45","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1007\/s00259-017-3875-1","volume":"45","author":"I Jambor","year":"2018","unstructured":"Jambor I, Kuisma A, Kahkonen E, Kemppainen J, Merisaari H, Eskola O et al (2018) Prospective evaluation of (18)F-FACBC PET\/CT and PET\/MRI versus multiparametric MRI in intermediate- to high-risk prostate cancer patients (FLUCIPRO trial). Eur J Nucl Med Mol Imaging 45:355\u2013364","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"7_CR46","doi-asserted-by":"publisher","first-page":"1246","DOI":"10.2214\/AJR.18.19585","volume":"211","author":"A Jena","year":"2018","unstructured":"Jena A, Taneja R, Taneja S, Singh A, Kumar V, Agarwal A et al (2018) Improving diagnosis of primary prostate cancer with combined (68)Ga-prostate-specific membrane antigen-HBED-CC simultaneous PET and multiparametric MRI and clinical parameters. AJR Am J Roentgenol 211:1246\u20131253","journal-title":"AJR Am J Roentgenol"},{"key":"7_CR47","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1002\/jmri.25384","volume":"45","author":"MS Lee","year":"2017","unstructured":"Lee MS, Cho JY, Kim SY, Cheon GJ, Moon MH, Oh S et al (2017) Diagnostic value of integrated PET\/MRI for detection and localization of prostate cancer: comparative study of multiparametric MRI and PET\/CT. J Magn Reson Imaging 45:597\u2013609","journal-title":"J Magn Reson Imaging"},{"key":"7_CR48","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1148\/radiol.2018172232","volume":"288","author":"SY Park","year":"2018","unstructured":"Park SY, Zacharias C, Harrison C, Fan RE, Kunder C, Hatami N et al (2018) Gallium 68 PSMA-11 PET\/MR imaging in patients with intermediate- or high-risk prostate cancer. Radiology 288:495\u2013505","journal-title":"Radiology"},{"key":"7_CR49","doi-asserted-by":"publisher","first-page":"1744","DOI":"10.1007\/s00259-014-2786-7","volume":"41","author":"T de Perrot","year":"2014","unstructured":"de Perrot T, Rager O, Scheffler M, Lord M, Pusztaszeri M, Iselin C et al (2014) Potential of hybrid (1)(8)F-fluorocholine PET\/MRI for prostate cancer imaging. Eur J Nucl Med Mol Imaging 41:1744\u20131755","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"7_CR50","doi-asserted-by":"publisher","first-page":"682","DOI":"10.1016\/j.eururo.2021.08.002","volume":"80","author":"L Emmett","year":"2021","unstructured":"Emmett L, Buteau J, Papa N, Moon D, Thompson J, Roberts MJ et al (2021) The additive diagnostic value of prostate-specific membrane antigen positron emission tomography computed tomography to multiparametric magnetic resonance imaging triage in the diagnosis of prostate cancer (PRIMARY): a prospective multicentre study. Eur Urol 80:682\u2013689","journal-title":"Eur Urol"},{"key":"7_CR51","doi-asserted-by":"publisher","first-page":"544","DOI":"10.1016\/j.euo.2023.11.008","volume":"7","author":"JP Buteau","year":"2024","unstructured":"Buteau JP, Moon D, Fahey MT, Roberts MJ, Thompson J, Murphy DG et al (2024) Clinical trial protocol for PRIMARY2: a multicentre, phase 3, randomised controlled trial investigating the additive diagnostic value of [(68)Ga]Ga-PSMA-11 positron emission tomography\/computed tomography in men with negative or equivocal multiparametric magnetic resonance imaging for the diagnosis of clinically significant prostate cancer. Eur Urol Oncol 7:544\u2013552","journal-title":"Eur Urol Oncol"},{"key":"7_CR52","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1016\/j.eururo.2021.11.019","volume":"82","author":"VH Meissner","year":"2022","unstructured":"Meissner VH, Rauscher I, Schwamborn K, Neumann J, Miller G, Weber W et al (2022) Radical prostatectomy without prior biopsy following multiparametric magnetic resonance imaging and prostate-specific membrane antigen positron emission tomography. Eur Urol 82:156\u2013160","journal-title":"Eur Urol"},{"key":"7_CR53","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1007\/s11307-017-1105-7","volume":"20","author":"AM Muehe","year":"2018","unstructured":"Muehe AM, Theruvath AJ, Lai L, Aghighi M, Quon A, Holdsworth SJ et al (2018) How to provide gadolinium-free PET\/MR cancer staging of children and young adults in less than 1 h: the Stanford approach. Mol Imaging Biol 20:324\u2013335","journal-title":"Mol Imaging Biol"},{"key":"7_CR54","doi-asserted-by":"publisher","first-page":"1","DOI":"10.2967\/jnumed.116.180182","volume":"58","author":"JA Siegel","year":"2017","unstructured":"Siegel JA, Pennington CW, Sacks B (2017) Subjecting radiologic imaging to the linear no-threshold hypothesis: a non sequitur of non-trivial proportion. J Nucl Med 58:1\u20136","journal-title":"J Nucl Med"},{"key":"7_CR55","doi-asserted-by":"publisher","first-page":"7","DOI":"10.2967\/jnumed.116.182667","volume":"58","author":"W Weber","year":"2017","unstructured":"Weber W, Zanzonico P (2017) The controversial linear no-threshold model. J Nucl Med 58:7\u20138","journal-title":"J Nucl Med"},{"key":"7_CR56","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1016\/j.mric.2019.01.012","volume":"27","author":"NS Kwatra","year":"2019","unstructured":"Kwatra NS, Lim R, Gee MS, States LJ, Vossough A, Lee EY (2019) PET\/MR Imaging:: current updates on pediatric applications. Magn Reson Imaging Clin N Am 27:387\u2013407","journal-title":"Magn Reson Imaging Clin N Am"},{"key":"7_CR57","doi-asserted-by":"publisher","first-page":"528","DOI":"10.1111\/pan.13390","volume":"28","author":"FJ Schneuer","year":"2018","unstructured":"Schneuer FJ, Bentley JP, Davidson AJ, Holland AJ, Badawi N, Martin AJ et al (2018) The impact of general anesthesia on child development and school performance: a population-based study. Paediatr Anaesth 28:528\u2013536","journal-title":"Paediatr Anaesth"}],"container-title":["Recent Results in Cancer Research","Molecular Imaging in Oncology - Volume 2"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/978-3-032-21415-7_7","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,21]],"date-time":"2026-05-21T11:02:29Z","timestamp":1779361349000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/978-3-032-21415-7_7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026]]},"ISBN":["9783032214140","9783032214157"],"references-count":57,"URL":"https:\/\/doi.org\/10.1007\/978-3-032-21415-7_7","relation":{},"ISSN":["0080-0015","2197-6767"],"issn-type":[{"value":"0080-0015","type":"print"},{"value":"2197-6767","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026]]},"assertion":[{"value":"22 May 2026","order":1,"name":"first_online","label":"First Online","group":{"name":"ChapterHistory","label":"Chapter History"}}]}}